Found: 70
Select item for more details and to access through your institution.
Individualizing Treatment with Statin Therapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy and safety of evolocumab in individuals with type 2 diabetes mellitus: primary results of the randomised controlled BANTING study.
- Published in:
- Diabetologia, 2019, v. 62, n. 6, p. 948, doi. 10.1007/s00125-019-4856-7
- By:
- Publication type:
- Article
Icosapent Ethyl, a Pure Ethyl Ester of Eicosapentaenoic Acid: Effects on Circulating Markers of Inflammation from the MARINE and ANCHOR Studies.
- Published in:
- American Journal of Cardiovascular Drugs, 2013, v. 13, n. 1, p. 37, doi. 10.1007/s40256-012-0002-3
- By:
- Publication type:
- Article
Consistency of Extended-Release Niacin/ Laropiprant Effects on Lp(a), ApoB, non-HDL-C, Apo A1, and ApoB/ApoA1 Ratio Across Patient Subgroups.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Consistency of Extended-Release Niacin/ Laropiprant Effects on Lp(a), ApoB, non-HDL-C, Apo A1, and ApoB/ApoA1 Ratio Across Patient Subgroups.
- Published in:
- American Journal of Cardiovascular Drugs, 2012, v. 12, n. 3, p. 197, doi. 10.2165/11631530-000000000-00000
- By:
- Publication type:
- Article
Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 diabetes after 26 weeks' treatment: A randomized open label study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2412, doi. 10.1111/dom.15560
- By:
- Publication type:
- Article
Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: A post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 5, p. 868, doi. 10.1111/dom.14645
- By:
- Publication type:
- Article
Evaluation of a New Formulation of Fenofibric Acid, ABT-335, Co-Administered with Statins: Study Design and Rationale of a Phase III Clinical Programme.
- Published in:
- Clinical Drug Investigation, 2008, v. 28, n. 10, p. 625, doi. 10.2165/00044011-200828100-00003
- By:
- Publication type:
- Article
Efficacy of Single-Pill Combination of Telmisartan 80mg and Hydrochlorothiazide 25 mg in Patients with Cardiovascular Disease Risk Factors: A Prospective Subgroup Analysis of a Randomized, Double-Blind, and Controlled Trial.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Efficacy of Single-Pill Combination of Telmisartan 80mg and Hydrochlorothiazide 25 mg in Patients with Cardiovascular Disease Risk Factors: A Prospective Subgroup Analysis of a Randomized, Double-Blind, and Controlled Trial.
- Published in:
- International Journal of Hypertension, 2013, p. 1, doi. 10.1155/2013/749830
- By:
- Publication type:
- Article
Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemia.
- Published in:
- Clinical Cardiology, 2003, v. 26, n. 1, p. 18, doi. 10.1002/clc.4960260105
- By:
- Publication type:
- Article
Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control.
- Published in:
- Vascular Health & Risk Management, 2015, v. 11, p. 165, doi. 10.2147/VHRM.S70907
- By:
- Publication type:
- Article
Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Colesevelam hydrochloride: reducing atherosclerotic coronary heart disease risk factors.
- Published in:
- Vascular Health & Risk Management, 2007, v. 3, n. 5, p. 733
- By:
- Publication type:
- Article
Colesevelam hydrochloride: reducing atherosclerotic coronary heart disease risk factors.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Adiposopathy, 'Sick Fat,' Ockham's Razor, and Resolution of the Obesity Paradox.
- Published in:
- Current Atherosclerosis Reports, 2014, v. 16, n. 5, p. 1, doi. 10.1007/s11883-014-0409-1
- By:
- Publication type:
- Article
Adiposopathy is a more rational treatment target for metabolic disease than obesity alone.
- Published in:
- Current Atherosclerosis Reports, 2006, v. 8, n. 2, p. 144, doi. 10.1007/s11883-006-0052-6
- By:
- Publication type:
- Article
185-OR: Efficacy and Safety of Bempedoic Acid in Patients with Diabetes, Prediabetes, and Normoglycemia: Analysis of Pooled Patient-Level Data from Four Phase 3 Clinical Trials.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-185-OR
- By:
- Publication type:
- Article
Effectiveness of Rosuvastatin in LDL-C Lowering and National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III Goal Attainment Compared to Other Statins Among Diabetes Patients.
- Published in:
- Diabetes, 2007, v. 56, p. A620
- By:
- Publication type:
- Article
Effect of Colesevelam HCl on Glycemic Control in Type 2 Diabetic Subjects Receiving Metformin Monotherapy.
- Published in:
- Diabetes, 2007, v. 56, p. A129
- By:
- Publication type:
- Article
Colesevelam HCl Improves the Lipid Profile in Type 2 Diabetic Subjects with Inadequate Glycemic Control on Metformin.
- Published in:
- Diabetes, 2007, v. 56, p. A129
- By:
- Publication type:
- Article
Efficacy and tolerability of a single-pill combination of telmisartan 80 mg and hydrochlorothiazide 25 mg according to age, gender, race, hypertension severity, and previous antihypertensive use: planned analyses of a randomized trial.
- Published in:
- Integrated Blood Pressure Control, 2013, v. 6, p. 1, doi. 10.2147/IBPC.S33104
- By:
- Publication type:
- Article
Lowering low-density lipoprotein cholesterol levels in patients with type 2 diabetes mellitus.
- Published in:
- International Journal of General Medicine, 2014, v. 7, p. 355, doi. 10.2147/ijgm.s65148
- By:
- Publication type:
- Article
Single-Pill Combination of Telmisartan and Hydrochlorothiazide: Studies and Pooled Analyses of Earlier Hypertension Treatment.
- Published in:
- High Blood Pressure & Cardiovascular Prevention, 2014, v. 21, n. 2, p. 119, doi. 10.1007/s40292-014-0041-8
- By:
- Publication type:
- Article
Single-Pill Combination of Telmisartan and Hydrochlorothiazide: Studies and Pooled Analyses of Earlier Hypertension Treatment.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Icosabutate, a Structurally Engineered Fatty Acid, Improves the Cardiovascular Risk Profile in Statin-Treated Patients with Residual Hypertriglyceridemia.
- Published in:
- Cardiology, 2016, v. 135, n. 1, p. 3, doi. 10.1159/000445047
- By:
- Publication type:
- Article
Efficacy and Safety of Alirocumab as Add-on Therapy in High-Cardiovascular-Risk Patients With Hypercholesterolemia Not Adequately Controlled With Atorvastatin (20 or 40 mg) or Rosuvastatin (10 or 20 mg): Design and Rationale of the ODYSSEY OPTIONS Studies
- Published in:
- Clinical Cardiology, 2014, v. 37, n. 10, p. 597, doi. 10.1002/clc.22327
- By:
- Publication type:
- Article
Effects of fenofibrate on atherogenic dyslipidemia in hypertriglyceridemic subjects.
- Published in:
- Clinical Cardiology, 2006, v. 29, n. 6, p. 268, doi. 10.1002/clc.4960290609
- By:
- Publication type:
- Article
Canagliflozin: Effects in overweight and obese subjects without diabetes mellitus.
- Published in:
- Obesity (19307381), 2014, v. 22, n. 4, p. 1042, doi. 10.1002/oby.20663
- By:
- Publication type:
- Article
Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight loss.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Current and Investigational Antiobesity Agents and Obesity Therapeutic Treatment Targets.
- Published in:
- Obesity (19307381), 2004, v. 12, n. 8, p. 1197, doi. 10.1038/oby.2004.151
- By:
- Publication type:
- Article
Sodium Glucose Co-transporter Type 2 (SGLT2) Inhibitors: Targeting the Kidney to Improve Glycemic Control in Diabetes Mellitus.
- Published in:
- Diabetes Therapy, 2013, v. 4, n. 2, p. 195, doi. 10.1007/s13300-013-0042-y
- By:
- Publication type:
- Article
Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester): Effects Upon High-Sensitivity C-Reactive Protein and Lipid Parameters in Patients With Metabolic Syndrome.
- Published in:
- Metabolic Syndrome & Related Disorders, 2015, v. 13, n. 6, p. 239, doi. 10.1089/met.2014.0137
- By:
- Publication type:
- Article
Extended-Release Niacin/Laropiprant Effects on Lipoprotein Subfractions in Patients with Type 2 Diabetes Mellitus.
- Published in:
- Metabolic Syndrome & Related Disorders, 2012, v. 10, n. 4, p. 260, doi. 10.1089/met.2012.0005
- By:
- Publication type:
- Article
Effects of Coadministered Ezetimibe Plus Fenofibrate in Mixed Dyslipidemic Patients with Metabolic Syndrome.
- Published in:
- Metabolic Syndrome & Related Disorders, 2011, v. 9, n. 2, p. 135, doi. 10.1089/met.2010.0068
- By:
- Publication type:
- Article
Anthropometric Measurements and Diabetes Mellitus: Clues to the “Pathogenic” and “Protective” Potential of Adipose Tissue.
- Published in:
- Metabolic Syndrome & Related Disorders, 2010, v. 8, n. 4, p. 307, doi. 10.1089/met.2009.0089
- By:
- Publication type:
- Article
Correction to: Role of Bempedoic Acid in Clinical Practice.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Role of Bempedoic Acid in Clinical Practice.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 4, p. 853, doi. 10.1007/s10557-021-07147-5
- By:
- Publication type:
- Article
Correction to: Assessment of the 1% of Patients with Consistent < 15% Reduction in Low-Density Lipoprotein Cholesterol: Pooled Analysis of 10 Phase 3 ODYSSEY Alirocumab Trials.
- Published in:
- Cardiovascular Drugs & Therapy, 2018, v. 32, n. 2, p. 181, doi. 10.1007/s10557-018-6792-z
- By:
- Publication type:
- Article
Assessment of the 1% of Patients with Consistent < 15% Reduction in Low-Density Lipoprotein Cholesterol: Pooled Analysis of 10 Phase 3 ODYSSEY Alirocumab Trials.
- Published in:
- Cardiovascular Drugs & Therapy, 2018, v. 32, n. 2, p. 175, doi. 10.1007/s10557-018-6784-z
- By:
- Publication type:
- Article
Icosapent Ethyl Effects on Fatty Acid Profiles in Statin-Treated Patients With High Triglycerides: The Randomized, Placebo-controlled ANCHOR Study.
- Published in:
- Cardiology & Therapy, 2019, v. 8, n. 1, p. 79, doi. 10.1007/s40119-019-0131-8
- By:
- Publication type:
- Article
Long-term (52–78 weeks) treatment with colesevelam HCl added to metformin therapy in type 2 diabetes mellitus patients.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2012, v. 5, p. 125, doi. 10.2147/DMSO.S32018
- By:
- Publication type:
- Article
Role of the Adipocyte, Free Fatty Acids, and Ectopic Fat in Pathogenesis of Type 2 Diabetes Mellitus: Peroxisomal Proliferator-Activated Receptor Agonists Provide a Rational Therapeutic Approach.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2004, v. 89, n. 2, p. 463, doi. 10.1210/jc.2003-030723
- By:
- Publication type:
- Article
The Melanocortin System as a Therapeutic Treatment Target for Adiposity and Adiposopathy.
- Published in:
- Drugs in R&D, 2006, v. 7, n. 5, p. 289, doi. 10.2165/00126839-200607050-00002
- By:
- Publication type:
- Article
Cholesterol Treatment Patterns and Cardiovascular Clinical Outcomes Associated with Colesevelam HCl and Ezetimibe.
- Published in:
- Drugs & Aging, 2014, v. 31, n. 9, p. 683, doi. 10.1007/s40266-014-0200-6
- By:
- Publication type:
- Article
Alirocumab as Add-On to Atorvastatin Versus Other Lipid Treatment Strategies: ODYSSEY OPTIONS I Randomized Trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
MBX-8025, A Novel Peroxisome Proliferator Receptor-δ Agonist: Lipid and Other Metabolic Effects in Dyslipidemic Overweight Patients Treated with and without Atorvastatin.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2011, v. 96, n. 9, p. 2889, doi. 10.1210/jc.2011-1061
- By:
- Publication type:
- Article
Individualizing Treatment with Statin Therapy.
- Published in:
- Clinician Reviews, 2018, p. S13
- By:
- Publication type:
- Article
Are post-treatment low-density lipoprotein subclass pattern analyses potentially misleading?
- Published in:
- Lipids in Health & Disease, 2010, v. 9, p. 136, doi. 10.1186/1476-511X-9-136
- By:
- Publication type:
- Article
Licogliflozin, a Novel SGLT1 and 2 Inhibitor: Body Weight Effects in a Randomized Trial in Adults with Overweight or Obesity.
- Published in:
- 2020
- By:
- Publication type:
- journal article